Home » Topics » Regulatory » Patents

Patents
RSS

Protease inhibitors especially useful for osteoporosis, periodontitis and arthritis reported by SB

Jan. 8, 1999

Novel cocaine analogues with promise in the treatment of cocaine addiction or overdose

Jan. 8, 1999

Chromanylsulfonyl(thio)ureas in early development at Hoechst Marion Roussel

Jan. 8, 1999

Sigma ligands synthesized at Jouveinal, evaluated and claimed for GI disorders

Jan. 8, 1999

Carbapenems in development at Sankyo

Jan. 7, 1999

Xanthine oxidase inhibitors for hyperuricemia, gout described by Yoshitomi in patent literature

Jan. 7, 1999

S-19777: novel ET antagonist of microbial origin

Jan. 7, 1999

Potent thrombin inhibitors with heterocyclic structure synthesized at Lilly

Jan. 7, 1999

ACAT-inhibitory urea derivatives claimed by Mitsubishi for lipid disorders

Jan. 7, 1999

Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho

Jan. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...